- Home
- TACT vs VTVT Comparison
TACT vs VTVT Comparison
Compare TACT & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACT
- VTVT
- Stock Information
- Founded
- TACT 1996
- VTVT 2015
- Country
- TACT United States
- VTVT United States
- Employees
- TACT N/A
- VTVT N/A
- Industry
- TACT Computer peripheral equipment
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- TACT Technology
- VTVT Health Care
- Exchange
- TACT Nasdaq
- VTVT Nasdaq
- Market Cap
- TACT 40.9M
- VTVT 38.8M
- IPO Year
- TACT 1996
- VTVT 2015
- Fundamental
- Price
- TACT $4.49
- VTVT $13.97
- Analyst Decision
- TACT Strong Buy
- VTVT Strong Buy
- Analyst Count
- TACT 1
- VTVT 1
- Target Price
- TACT $7.50
- VTVT $35.00
- AVG Volume (30 Days)
- TACT 18.5K
- VTVT 8.5K
- Earning Date
- TACT 03-11-2025
- VTVT 03-12-2025
- Dividend Yield
- TACT N/A
- VTVT N/A
- EPS Growth
- TACT N/A
- VTVT N/A
- EPS
- TACT N/A
- VTVT N/A
- Revenue
- TACT $46,418,000.00
- VTVT $1,000,000.00
- Revenue This Year
- TACT N/A
- VTVT N/A
- Revenue Next Year
- TACT $16.86
- VTVT N/A
- P/E Ratio
- TACT N/A
- VTVT N/A
- Revenue Growth
- TACT N/A
- VTVT 11011.11
- 52 Week Low
- TACT $3.32
- VTVT $7.38
- 52 Week High
- TACT $7.97
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- TACT 60.99
- VTVT 46.05
- Support Level
- TACT $4.38
- VTVT $13.90
- Resistance Level
- TACT $4.60
- VTVT $14.35
- Average True Range (ATR)
- TACT 0.18
- VTVT 0.52
- MACD
- TACT 0.02
- VTVT 0.04
- Stochastic Oscillator
- TACT 61.31
- VTVT 38.59
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.